Marco Cavaleri, Head of Health Threats and Vaccines Strategy at the European Medicines Agency has revealed today that the Omicron variant BA.2.75 is now being monitored as a Variant of Concern (VOC) by the ECDC.

The ECDC webpage dedicated to tracking SARS-CoV-2 variants hasn’t yet been updated – BA.2.75 is still listed as a Variant of Interest (VOI) there, but designating BA.2.75 as a VOC is a big step up in the threat profile for this particular variant.

The ECDC SARS-CoV-2 variants page has yet to be updated, it currently still lists BA.2.75 as a Variant of Interest:

ECDC SARS-CoV-2 variants page

We will update this post as more information becomes available about this change in designation.

BA.2.75.2 “exhibits more extreme antibody escape than any variant we’ve seen so far”